Investing Center Preview – Manage your investments and watch your net worth grow.
TENX:NASDAQ – Small Cap Stock (Biotechnology)
Tenax Therapeutics Inc – TENX Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
7.66 | 0.17 (+2.27%) | 3.25 - 7.91 | 41.5 thousand (Below Avg) |
Market data as of 12:05PM 10/08/25. Quotes are delayed by at least 15 min.
Overview - TENX
Open | 7.54 |
---|---|
Previous Close | 7.49 |
Day's Range | 7.49 - 7.70 |
Market Cap | 34.9M |
Avg Volume (10 Day) | 172.5K |
Price/Earnings (Trailing 12 Mo.) | 2.6x |
Earnings Per Share (Trailing 12 Mo.) | -315.77 |
Dividend Yield | No Dividend |
One-Click Scorecard - TENX


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Pass |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - TENX
No news headlines available for TENX
Industry Position - TENX
TENX | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | -- | |
LT Debt/Equity | -- | |
Earnings Yield | 38.38% | |
Price/Sales | -- |
Competitors - TENX
Company | Last | Change |
---|---|---|
Vyome Holdings Inc | 5.91 | -4.91% |
0.09 | -1.36% | |
Iterum Therapeutics PLC | 0.78 | +2.63% |
IO Biotech Inc | 0.51 | -0.51% |
458.00 | +14.79% |
Data is delayed by at least 15 min.